Diagnostic and prognostic value of fibroblast growth factor 23 in acute kidney injury: systematic review and meta-analysis. [PDF]
Ren FailPei X, Gao H, Zhang L.
europepmc +1 more source
Role of fibroblast growth factor 23 in predicting CKD progression and prognosis: a systematic review and meta-analysis. [PDF]
PeerJHsu JW, Wang HP, Chiang TI.
europepmc +1 more source
Severe Hypocalcemia and Hypophosphatemia Following Ferric Carboxymaltose in a Patient With Roux-en-Y Gastric Bypass. [PDF]
CureusElhassan A, Ali I.
europepmc +1 more source
Orthopaedic diagnostic pitfalls in fibroblast growth factor 23-mediated hypophosphatemic rickets/osteomalacia in fibrous dysplasia/McCune-Albright syndrome: Two burosumab-treated cases. [PDF]
Bone RepNakagawa T +8 more
europepmc +1 more source
Burosumab as bridging therapy in autosomal dominant hypophosphatemic rickets with femoral fracture nonunion and iron deficiency. [PDF]
JBMR PlusRakusa M, Kocjan T.
europepmc +1 more source
Bone <i>FGF23</i> expression and renal regulatory responses to excess phosphate consumption by juvenile swine. [PDF]
JBMR PlusGrez-Capdeville M +3 more
europepmc +1 more source
Phosphate: An Anion Controlling Metabolic Functions. [PDF]
NutrientsTarantino U +6 more
europepmc +1 more source
Editorial: Bone metastases in endocrine cancers: advances in diagnosis, treatment, and prevention. [PDF]
Front Endocrinol (Lausanne)Mandal CC, Rhoades JA.
europepmc +1 more source
When X Does Not Mark the Spot: Autosomal Dominant and Recessive Forms of Renal Hypophosphatemic Rickets and Osteomalacia. [PDF]
Curr Osteoporos RepFerreira CR, Imel EA.
europepmc +1 more source
Autosomal dominant hypophosphatemic rickets caused by a novel pathogenic variant in <i>FGF23</i>. [PDF]
JCEM Case RepFrancis B +3 more
europepmc +1 more source